Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival

Journal of Clinical Pathology

Volumn 61, Issue 3, 2008, Pages 311-316

  Milne, Anya N A ^a,b   Carvalho, R ^c   Jansen, M ^a   Kranenbarg, E K ^d   Van De Velde, C J H ^d   Morsink, F M ^a   Musler, A R ^b   Weterman, M A J ^b   Offerhaus, G J A ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MRC HOLLAND   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; ISOPROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; AMPUTATION STUMP; ANTIBODY DETECTION; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; EARLY CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR WEIGHT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; STOMACH CANCER; SURVIVAL TIME; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGE OF ONSET; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; CYCLIN E; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; MOLECULAR WEIGHT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN ISOFORMS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 40449138458     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.042648     Document Type: Article

References (59)

1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Theuer CP, Kurosaki T, Taylor TH, et al. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 1998;83:25-33.
3. Kokkola A, Sipponen P. Gastric carcinoma in young adults. Hepatogastroenterology 2001;48:1552-5.
4. Maehara Y, Emi Y, Baba H, et al. Recurrences and related characteristics of gastric cancer. Br J Cancer 1996;74:975-9.
5. Nakamura T, Yao T, Niho Y, et al. A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 1999;71:214-9.
6. Carvalho R, Milne AN, Van Rees BP, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 2004;204:75-83.
7. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
8. Matley PJ, Dent DM, Madden MV, et al. Gastric carcinoma in young adults. Ann Surg 1988;208:593-6.
9. Theuer CP, de Virgilio C, Keese G, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 1996;172:473-7.
10. Lai IR, Lee WJ, Chen CN, et al. Gastric cancer in the young. Hepatogastroenterology 1997;44:1641-5.
11. Katai H, Sasako M, Sano T, et al. Gastric carcinoma in young adults. Jpn J Clin Oncol 1996;26:139-43.
12. Medina-Franco H, Heslin MJ, Cortes-Gonzalez R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000;7:515-9.
13. Peddanna N, Holt S, Verma RS. Genetics of gastric cancer. Anticancer Res 1995;15:2055-64.
14. Kikuchi S, Nakajima T, Nishi T, et al. Association between family history and gastric carcinoma among young adults. Jpn J Cancer Res 1996;87:332-6.
15. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
16. Rugge M, Shiao YH, Busatto G, et al. The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol 2000;53:207-10.
17. Parsonnet J, Vandersteen D, Goates J, et al. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991;83:640-3.
18. Moroy T, Geisen C. Cyclin E. Int J Biochem Cell Biol 2004;36:1424-39.
19. Hinchcliffe EH, Li C, Thompson EA, et al. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 1999;283:851-4.
20. Lacey KR, Jackson PK, Stearns T. Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 1999;96:2817-22.
21. Akli S, Keyomarsi K. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther 2003;2:S38-47.
22. Mendez J. Cell proliferation without cyclin E-CDK2. Cell 2003;114:398-9.
23. Geng Y, Yu Q, Sicinska E, et al. Cyclin E ablation in the mouse. Cell 2003;114:431-43.
24. Ortega S, Prieto I, Odajima J, et al. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 2003;35:25-31.
25. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J 1999;13:773-80.
26. Schraml P, Bucher C, Bissig H, et al. Cyclin E overexpression and amplification in human tumours. J Pathol 2003;200:375-82.
27. Harwell RM, Porter DC, Danes C, et al. Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 2000;60:481-9.
28. Wang XD, Rosales JL, Magliocco A, et al. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003;22:769-74.
29. Porter DC, Zhang N, Danes C, et al. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001;21:6254-69.
30. Keyomarsi K, Conte D Jr, Toyofuku W, et al. Deregulation of cyclin E in breast cancer. Oncogene 1995;11:941-50.
31. Porter DC, Keyomarsi K. Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Res 2000;28:E101.
32. Harwell RM, Porter DC, Danes C, et al. Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 2000;60:481-9.
33. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-75.
34. Tersmette AC, Offerhaus GJ, Giardiello FM, et al. Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960. Gastroenterology 1991;101:148-53.
35. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999;340:908-14.
36. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069-77.
37. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
38. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-75.
39. Myung N, Kim MR, Chung IP, et al. Loss of p16 and p27 is associated with progression of human gastric cancer. Cancer Lett 2000;153:129-36.
40. Li K, Lin SY, Brunicardi FC, et al. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. 2003;63:3593-7.
41. Cox D. Regression models and life tables. J R Statist Soc B 1972;34:187-220.
42. Milne AN, Carvalho R, Morsink FM, et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 2006;19:564-72.
43. Dobashi Y, Jiang SX, Shoji M, et al. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. J Pathol 2003;199:208-20.
44. Del Pizzo JJ, Borkowski A, Jacobs SC, et al. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 1999;155:1129-36.
45. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000;157:787-94.
46. Kitahara K, Yasui W, Kuniyasu H, et al. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 1995;62:25-8.
47. Keyomarsi K, O'Leary N, Molnar G, et al. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994;54:380-5.
48. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999;401:297-300.
49. Hubalek MM, Widschwendter A, Erdel M, et al. Cyclin E dysregulation and chromosomal instability in endometrial cancer. Oncogene 2004;23:4187-92.
50. Berglund P, Stighall M, Jirstrom K, et al. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers. Cancer Res 2005;65:9727-34.
51. Takano Y, Kato Y, van Diest PJ, et al. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000;156:585-94.
52. Chetty R, Sitti CW. Cyclin E immunoexpression in gastric cancer does not correlate with clinicopathological parameters. Histopathology 2003;42:66-9.
53. Muller W, Noguchi T, Wirtz HC, et al. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer. J Pathol 1999;189:186-93.
54. Del Pizzo JJ, Borkowski A, Jacobs SC, et al. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 1999;155:1129-36.
55. Dobashi Y, Jiang SX, Shoji M, et al. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. J Pathol 2003;199:208-20.
56. Bito T, Ueda M, Ito A, et al. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions. J Cutan Pathol 1997;24:305-8.
57. Ishikawa Y. Wnt signaling and orthopedic diseases. Am J Pathol 2005;167:1-3.
58. Sharpless NE, DePinho RA. Cancer: crime and punishment. Nature 2005;436:636-7.
59. Carvalho R, Milne AN, Polak M, et al. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas. Oncogene 2005;24:8252-8.